Read + Share
Amedeo Smart
Independent Medical Education
Ji D, Chen Y, Bi J, Shang Q, et al. Entecavir plus Biejia-Ruangan compound reduces the risk of hepatocellular carcinoma in Chinese patients with chronic hepatitis B. J Hepatol 2022 Aug 16. pii: S0168-8278(22)02982.PMID: 35985545
Email
LinkedIn
Facebook
Twitter
Privacy Policy